Should vitamin D status be assessed in patients with congestive heart failure?

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 9, 2010, Pages 627-632

  Rendina, D ^a   De Filippo, G ^b   Strazzullo, P ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G RUMMO HOSPITAL   (Italy)

Author keywords

Congestive heart failure; Vitamin D; Vitamin D receptor

Indexed keywords

1,25-DIHYDROXYVITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; CALCITRIOL; CALCITRIOL RECEPTOR; DRUG DERIVATIVE; VITAMIN D;

ANIMAL; BLOOD; HEART FAILURE; HUMAN; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; VITAMIN D DEFICIENCY;

ANIMALS; HEART FAILURE; HUMANS; RECEPTORS, CALCITRIOL; RENIN-ANGIOTENSIN SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78049403175     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2010.06.003     Document Type: Short Survey

References (59)

1. Young J.B. The global epidemiology of heart failure. Med Clin North Am 2004, 88:1135-1143.
2. Ameri P., Ronco D., Casu M., Denegri A., Bovio M., Menoni S., et al. High prevalence of vitamin D deficiency and its association with left ventricular dilation: An echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis 2010, 20(9):633-640.
3. Przybylski R., McCune S., Hollis B., Simpson R.U. Vitamin D deficiency in the spontaneously hypertensive heart failure [SHHF] prone rat. Nutr Metab Cardiovasc Dis 2010, 20(9):641-646.
4. Fliser D., Franek E., Joest M., Block S., Mutschler E., Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int 1997, 51:1196-1204.
5. Norman A.W. From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 2008, 88:491S-499S.
6. Dusso A.S., Brown A.J., Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005, 289:F8-F28.
7. White K.E., Larsson T.E., Econs M.J. The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23. Endocr Rev 2006, 27:221-241.
8. Perwad F., Zhang M.Y., Tenenhouse H.S., Portale A.A. Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 2007, 293:F1577-F1583.
9. Haussler M.R., Haussler C.A., Bartik L., Whitfield G.K., Hsieh J.C., Slater S., et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 2008, 66:S98-S112.
10. Bouillon R., Bischoff-Ferrari H., Willett W. Vitamin D and health: perspectives from mice and man. J Bone Miner Res 2008, 23:974-979.
11. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
12. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004, 89-90:387-392.
13. Kong J., Li Y.C. Effect of angiotensin II type I receptor antagonist and angiotensin-converting enzyme inhibitor on vitamin D receptor null mice. Am J Physiol Regul Integr Comp Physiol 2003, 285:R255-R261.
14. Sigmund C.D., Okuyama K., Ingelfinger J., Jones C.A., Mullins J.J., Kane C., et al. Isolation and characterization of renin-expressing cell lines from transgenic mice containing a renin-promoter viral oncogene fusion construct. J Biol Chem 1990, 265:19916-19922.
15. Zhou C., Lu F., Cao K., Xu D., Goltzman D., Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int 2008, 74:170-179.
16. Qiao G., Kong J., Uskokovic M., Li Y.C. Analogs of 1alpha,25-dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis. J Steroid Biochem Mol Biol 2005, 96:59-66.
17. Kristal-Boneh E., Froom P., Harari G., Ribak J. Association of calcitriol and blood pressure in normotensive men. Hypertension 1997, 30:1289-1294.
18. Lind L., Hanni A., Lithell H., Hvarfner A., Sorensen O.H., Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995, 8:894-901.
19. Burgess E.D., Hawkins R.G., Watanabe M. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990, 3:903-905.
20. Kendrick J., Targher G., Smits G., Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009, 205:255-260.
21. Resnick L.M., Muller F.B., Laragh J.H. Calcium regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986, 105:649-654.
22. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633-1637.
23. Lind L., Wengle B., Wide L., Ljunghall S. Reduction of blood pressure during long term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double blind, placebo controlled study. Am J Hypertens 1989, 2:20-25.
24. Kimura Y., Kawamura M., Owada M., Oshima T., Murooka M., Fujiwara T., et al. Effectiveness of 1,25- dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern Med 1999, 38:31-35.
25. Park C.W., Oh Y.S., Shin Y.S., Kim C.M., Kim Y.S., Kim S.Y., et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999, 33:73-81.
26. Freundlich M., Quiroz Y., Zhang Z., Zhang Y., Bravo Y., Weisinger J.R., et al. Suppression of renin-angiotensin gene expression in the kidney by paracalcitol. Kidney Int 2008, 74:1394-1402.
27. Peechakara S.V., Pittas A.G. Vitamin D as a potential modifier of diabetes risk. Nat Clin Pract Endocrinol Metab 2008, 4:182-183.
28. Johnson J.A., Grande J.P., Roche P.C., Kumar R. Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas. Am J Physiol 1994, 267:E356-E360.
29. Bland R., Markovic D., Hills C.E., Hughes S.V., Chan S.L., Squires P.E., et al. Expression of 25-hydroxyvitamin D3-1 α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004, 89-90:121-125.
30. Maestro B., Davila N., Carranza M.C., Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003, 84:223-230.
31. Maestro B., Molero S., Bajo S., Dàvila N., Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct 2002, 20:227-232.
32. Maestro B., Campion J., Davila N., Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000, 47:383-391.
33. Bischoff H.A., Borchers M., Gudat F., Duermueller U., Theiler R., Stähelin H.B., et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. Histochem J 2001, 33:19-24.
34. Imagawa M., Tsuchiya T., Nishihara T. Identification of inducible genes at the early stage of adipocyte differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 1999, 254:299-305.
35. Wollheim C.B., Sharp G.W. Regulation of insulin release by calcium. Physiol Rev 1981, 61:914-973.
36. Wright D.C., Hucker K.A., Holloszy J.O., Han D.H. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes 2004, 53:330-335.
37. Draznin B., Sussman K., Kao M., Lewis D., Sherman N. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem 1987, 262:14385-14388.
38. Pittas A.G., Lau J., Hu F.B., Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007, 92:2017-2029.
39. Pittas A.G., Dawson-Hughes B., Li T., Van Dam R.M., Willett W.C., Manson J.E., et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006, 29:650-656.
40. Hypponen E., Laara E., Reunanen A., Jarvelin M.-R., Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth cohort study. Lancet 2001, 358:1500-1503.
41. Talmor Y., Golan E., Benchetrit S., Bernheim J., Klein O., Green J., et al. Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am J Physiol Renal Physiol 2008, 294:F1059-F1064.
42. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988, 318:1315-1321.
43. Talmor Y., Bernheim J., Klein O., Green J., Rashid G. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro. Eur J Clin Invest 2008, 38:548-554.
44. Gysemans C.A., Cardozo A.K., Callewaert H., Giulietti A., Hulshagen L., Bouillon R., et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005, 146:1956-1964.
45. van Etten E., Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005, 97:93-101.
46. Rabinovitch A., Suarez-Pinzon W.L., Sooy K., Strynadka K., Christakos S. Expression of calbindin-D (28k) in a pancreatic islet beta-cell line protects against cytokine-induced apoptosis and necrosis. Endocrinology 2001, 142:3649-3655.
47. Shoji T., Shinohara K., Kimoto E., Emoto M., Tahara H., Koyama H., et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 2004, 19:179-184.
48. Sugden J.A., Davies J.I., Witham M.D., Morris A.D., Struthers A.D. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008, 25:320-325.
49. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
50. Reis J.P., von Mühlen D., Miller E.R., Michos E.D., Appel L.J. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009, 124:371-379.
51. Melamed M.L., Michos E.D., Post W., Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
52. Kilkkinen A., Knekt P., Aro A., Rissanen H., Marniemi J., Heliövaara M., et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 2009, 170:1032-1039.
53. Binkley N., Krueger D., Lensmeyer G. 25-hydroxyvitamin D measurement, 2009: a review for clinicians. J Clin Densitom 2009, 12:417-427.
54. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998, 338:777-783.
55. Sambrook P.N., Chen J.S., March L.M., Cameron I.D., Cumming R.G., Lord S.R., et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab 2004, 89:5477-5481.
56. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
57. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7:439-443.
58. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80:1689S-1696S.
59. Wagner C.L., Greer F.R. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008, 122:1142-1152. American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition.